Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

ALLERGIC REACTION UPON INTRAVITREAL ADMINISTRATION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS.

Meredith GG, Schkade PA, Joondeph BC.

Retin Cases Brief Rep. 2017 Mar 15. doi: 10.1097/ICB.0000000000000581. [Epub ahead of print]

PMID:
28301410
2.

IS A POSTOPERATIVE DAY ONE EXAMINATION NEEDED AFTER UNCOMPLICATED VITREORETINAL SURGERY?

Zick J, Joondeph BC.

Retina. 2017 Feb 10. doi: 10.1097/IAE.0000000000001544. [Epub ahead of print]

PMID:
28196057
3.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

4.

Anti-vascular endothelial growth factor injection technique for recurrent exudative macular degeneration in a telescope-implanted eye.

Joondeph BC.

Retin Cases Brief Rep. 2014 Fall;8(4):342-4. doi: 10.1097/ICB.0000000000000065.

PMID:
25372544
5.

Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.

Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A, Kampik A, Jaffe GJ, Toth CA; MIVI-TRUST Study Group.

Ophthalmology. 2015 Jan;122(1):117-22. doi: 10.1016/j.ophtha.2014.07.045. Epub 2014 Sep 18.

PMID:
25240630
6.

Ocular trauma from the "knockout game".

Joondeph BC.

Case Rep Ophthalmol Med. 2014;2014:285942. doi: 10.1155/2014/285942. Epub 2014 Jul 13.

7.

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K; FAME Study Group.

Ophthalmology. 2014 Oct;121(10):1892-903. doi: 10.1016/j.ophtha.2014.04.019. Epub 2014 Jun 14.

8.

Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.

Cao JH, Mulvahill M, Zhang L, Joondeph BC, Dacey MS.

Ophthalmology. 2014 Oct;121(10):1871-6. doi: 10.1016/j.ophtha.2014.04.012. Epub 2014 Jun 3.

PMID:
24907061
9.

Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.

Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF; Macula Society CSC Collaborative Study Group, Research and Education Committee and Website Committee.

Ophthalmology. 2014 May;121(5):1073-8. doi: 10.1016/j.ophtha.2013.11.040. Epub 2014 Jan 16.

PMID:
24439758
10.

Retinal Detachment due to CrossFit Training Injury.

Joondeph SA, Joondeph BC.

Case Rep Ophthalmol Med. 2013;2013:189837. doi: 10.1155/2013/189837. Epub 2013 Sep 11.

11.

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.

12.

Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA; MIVI-TRUST Study Group.

N Engl J Med. 2012 Aug 16;367(7):606-15. doi: 10.1056/NEJMoa1110823.

13.

Controlled aspiration of subfoveal perfluorocarbon liquid using a novel microcannula.

Joondeph BC.

Retina. 2011 May;31(5):991-3. doi: 10.1097/IAE.0b013e3182150565. No abstract available.

PMID:
21487332
14.

Evaluation and treatment of some common medical eye conditions encountered in patients with TBI, stroke and other neurological conditions in an acute care rehabilitation hospital.

Joondeph B, Hawes M, Politzer T.

NeuroRehabilitation. 2010;27(3):243-6. doi: 10.3233/NRE-2010-0604. Review. No abstract available.

PMID:
21098993
15.

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study.

Friberg TR, Tolentino M; LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M.

Br J Ophthalmol. 2010 Dec;94(12):1611-7. doi: 10.1136/bjo.2009.174946. Epub 2010 May 14.

16.

Terson's Syndrome Managed with 25-Gauge Vitrectomy.

Joondeph BC, Nguyen H, Politzer T, Weintraub A.

Ophthalmic Surg Lasers Imaging. 2010 Mar 9:1-3. doi: 10.3928/15428877-20100215-85. [Epub ahead of print]

PMID:
20337288
17.

Large-spot subthreshold infrared laser to treat diabetic macular edema.

Squirrell DM, Stewart AW, Joondeph BC, Danesh-Meyer HV, McGhee CN, Donaldson ML.

Retina. 2008 Apr;28(4):615-21. doi: 10.1097/IAE.0b013e31815ee567.

PMID:
18398365
18.

Diagnostic and therapeutic challenges.

Chan CK, Berger B, Joondeph BC.

Retina. 2007 Jan;27(1):101-5. No abstract available.

PMID:
17218923
19.

Ocular coherence tomography findings with retained submacular perfluoron.

Joondeph BC, Nguyen H.

Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):85-6.

PMID:
16451267
20.

Endophthalmitis after pars plana vitrectomy: a New Zealand experience.

Joondeph BC, Blanc JP, Polkinghorne PJ.

Retina. 2005 Jul-Aug;25(5):587-9.

PMID:
16077355

Supplemental Content

Loading ...
Support Center